Dossier Registration

Hostrin Life Sciences > Dossier Registration

Dossier Registration

Registration of Dossier for the pharmaceutical product is a document that contains all the technical data (administrative, quality, nonclinical and clinical) which has to be approved / registered / marketed in a country. It is more commonly called as the New Drug Application (NDA) in the USA or Marketing Authorization Application (MAA) in the European Union (EU) and other countries, or simply Registration Dossier. Basically, this consists of data proving that the drug has quality, efficacy and safety properties suitable for the intended use, additional administrative documents, samples of finished product or related substances and reagents necessary to perform analyzes of finished product. Therefore, they are the vehicle in a country through which drug sponsors formally propose that the Regulatory Agencies approve a new pharmaceutical for sale and marketing.


October 23, 2015


Media, Platform

Custom Field

Enter some text here